Adverse reactions during transfusion of thawed haematopoietic progenitor cells from apheresis are closely related to the number of granulocyte cells in the leukapheresis product

Vox Sanguinis

Volumn 99, Issue 3, 2010, Pages 267-273

  Martin Henao G A ^a   Resano, P M ^a   Villegas, J M S ^a   Manero, P P ^a   Sanchez J M ^a   Bosch, M P ^a   Codins, A E ^a   Bruguera, M S ^a   Infante, L R ^a   Oyarzabal, A P ^a   Soldevila, R N ^a   Caiz, D C ^a   Bosch, L M ^a   Barbeta, E C ^a   Ronda, J R G ^a  

^a Blood and Tissue Bank   (Spain)

Author keywords

adverse reactions; apheresis; cryopreservation; infusion

Indexed keywords

DIMETHYL SULFOXIDE;

ADOLESCENT; ADULT; AGED; APHERESIS; ARTICLE; BLOOD TRANSFUSION REACTION; CHILD; CRYOPRESERVATION; ERYTHROCYTE; FEMALE; GASTROINTESTINAL SYMPTOM; GRANULOCYTE; HEMATOPOIETIC STEM CELL; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; LEUKAPHERESIS; MAJOR CLINICAL STUDY; MALE; NAUSEA; PATHOGENESIS; PRESCHOOL CHILD; PRIORITY JOURNAL; RESPIRATORY TRACT DISEASE; SCHOOL CHILD; SEIZURE; THAWING; UNIVARIATE ANALYSIS;

ADOLESCENT; ADULT; AGED; CHILD; CHILD, PRESCHOOL; CRYOPRESERVATION; CRYOPROTECTIVE AGENTS; DIMETHYL SULFOXIDE; FEMALE; GASTROINTESTINAL DISEASES; GRANULOCYTES; HUMANS; LEUKAPHERESIS; LEUKOCYTE COUNT; MALE; MIDDLE AGED; NEOPLASMS; PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; RESPIRATION DISORDERS; SEIZURES; TRANSPLANTATION, AUTOLOGOUS; TRANSPLANTATION, HOMOLOGOUS;

EID: 77956642323     PISSN: 00429007     EISSN: 14230410     Source Type: Journal    
DOI: 10.1111/j.1423-0410.2010.01341.x     Document Type: Article

References (42)

1. Rowley SD: Hematopoietic stem cell cryopreservation: a review of current techniques. J Hematother 1992 1: 233 250
2. Alessandrino P, Bernasconi P, Caldera D, Colombo A, Bonfichi M, Malcovati L, Klersy C, Martinelli G, Maiocchi M, Pagnucco G, Varettoni M, Perotti C, Bernasconi C: Adverse events occurring during bone marrow or peripheral blood progenitor cell infusion: analysis of 126 cases. Bone Marrow Transplant 1999 23: 533 537
3. Bauwens D, Hantson P, Laterre PF, Michaux L, Latinne D, De Tourtchaninoff M, Cosnard G, Hernalsteen D: Recurrent seizure and sustained encephalopathy associated with dimethylsulfoxide-preserved stem cell infusion. Leuk Lymphoma 2005 46: 1671 1674
4. Benekli M, Anderson B, Wentling D, Bernstein S, Czuczman M, McCarthy P: Severe respiratory depression after dimethylsulphoxide-containing autologous stem cell infusion in a patient with AL amyloidosis. Bone Marrow Transplant 2000 25: 1299 1301
5. Chen-Plotkin AS, Vossel KA, Samuels MA, Chen MH: Encephalopathy, stroke, and myocardial infarction with DMSO use in stem cell transplantation. Neurology 2007 68: 859 861
6. Corso S, Vukelja SJ, Wiener D, Baker WJ: Diffuse alveolar hemorrhage following autologous bone marrow infusion. Bone Marrow Transplant 1993 12: 301 303
7. Davis JM, Rowley SD, Braine HG, Piantadosi S, Santos GW: Clinical toxicity of cryopreserved bone marrow graft infusion. Blood 1990 75: 781 786
8. Dhodapkar M, Goldberg SL, Tefferi A, Gertz MA: Reversible encephalopathy after cryopreserved peripheral blood stem cell infusion. Am J Hematol 1994 45: 187 188
9. Donmez A, Tombuloglu M, Gungor A, Soyer N, Saydam G, Cagirgan S: Clinical side effects during peripheral blood progenitor cell infusion. Transfus Apher Sci 2007 36: 95 101
10. Higman MA, Port JD, Beauchamp NJ Jr. , Chen AR: Reversible leukoencephalopathy associated with re-infusion of DMSO preserved stem cells. Bone Marrow Transplant 2000 26: 797 800
11. Hoyt R, Szer J, Grigg A: Neurological events associated with the infusion of cryopreserved bone marrow and/or peripheral blood progenitor cells. Bone Marrow Transplant 2000 25: 1285 1287
12. Junior AM, Arrais CA, Saboya R, Velasques RD, Junqueira PL, Dulley FL: Neurotoxicity associated with dimethylsulfoxide-preserved hematopoietic progenitor cell infusion. Bone Marrow Transplant 2008 41: 95 96
13. Keung YK, Lau S, Elkayam U, Chen SC, Douer D: Cardiac arrhythmia after infusion of cryopreserved stem cells. Bone Marrow Transplant 1994 14: 363 367
14. Lopez-Jimenez J, Cervero C, Munoz A, Hernandez-Madrid A, Fernandez Pineda J, Garcia Larana J, Moro C, Maldonado M, Perez Oteyza J, Otheo E, Sastre JL, Ramos P, Odriozola J, Navarro JL: Cardiovascular toxicities related to the infusion of cryopreserved grafts: results of a controlled study. Bone Marrow Transplant 1994 13: 789 793
15. Miniero R, Saroglia E, Busca A, Vassallo E, Barattia G, Madon E: Electrocardiographic alterations occurring during cryopreserved bone marrow infusion. Bone Marrow Transplant 1994 14: 664 665
16. Otrock ZK, Beydoun A, Barada WM, Masroujeh R, Hourani R, Bazarbachi A: Transient global amnesia associated with the infusion of DMSO-cryopreserved autologous peripheral blood stem cells. Haematologica 2008 93: e36 e37
17. Stroncek DF, Fautsch SK, Lasky LC, Hurd DD, Ramsay NK, McCullough J: Adverse reactions in patients transfused with cryopreserved marrow. Transfusion 1991 31: 521 526
18. Sugarman J, Bashore TM, Ohman EM, Jones R, Peters WP: Hypertension and reversible myocardial depression associated with autologous bone marrow transplantation. Am J Med 1990 88: 52N 55N
19. Zenhausern R, Tobler A, Leoncini L, Hess OM, Ferrari P: Fatal cardiac arrhythmia after infusion of dimethyl sulfoxide-cryopreserved hematopoietic stem cells in a patient with severe primary cardiac amyloidosis and end-stage renal failure. Ann Hematol 2000 79: 523 526
20. Abrahamsen JF, Bakken AM, Bruserud O: Cryopreserving human peripheral blood progenitor cells with 5-percent rather than 10-percent DMSO results in less apoptosis and necrosis in CD34+ cells. Transfusion 2002 42: 1573 1580
21. Rowley SD, Feng Z, Chen L, Holmberg L, Heimfeld S, MacLeod B, Bensinger WI: A randomized phase III clinical trial of autologous blood stem cell transplantation comparing cryopreservation using dimethylsulfoxide vs dimethylsulfoxide with hydroxyethylstarch. Bone Marrow Transplant 2003 31: 1043 1051
22. Martin-Henao GA, Torrico C, Azqueta C, Amill B, Querol S, Garcia J: Cryopreservation of hematopoietic progenitor cells from apheresis at high cell concentrations does not impair the hematopoietic recovery after transplantation. Transfusion 2005 45: 1917 1924
23. Martino M, Morabito F, Messina G, Irrera G, Pucci G, Iacopino P: Fractionated infusions of cryopreserved stem cells may prevent DMSO-induced major cardiac complications in graft recipients. Haematologica 1996 81: 59 61
24. Lemarie C, Calmels B, Malenfant C, Arneodo V, Blaise D, Viret F, Bouabdallah R, Ladaique P, Viens P, Chabannon C: Clinical experience with the delivery of thawed and washed autologous blood cells, with an automated closed fluid management device: CytoMate. Transfusion 2005 45: 737 742
25. Rodriguez L, Velasco B, Garcia J, Martin-Henao GA: Evaluation of an automated cell processing device to reduce the dimethyl sulfoxide from hematopoietic grafts after thawing. Transfusion 2005 45: 1391 1397
26. Syme R, Bewick M, Stewart D, Porter K, Chadderton T, Gluck S: The role of depletion of dimethyl sulfoxide before autografting: on hematologic recovery, side effects, and toxicity. Biol Blood Marrow Transplant 2004 10: 135 141
27. Del ML, Venturini M, Viscoli C, Bergaglio M, Signorini A, Bighin C, Bertelli G, Semino C, Pietra G, Bertoglio S, Sertoli MR, Lambiase A, Rosso R, Melioli G: Intensified chemotherapy supported by DMSO-free peripheral blood progenitor cells in breast cancer patients. Ann Oncol 2001 12: 505 508
28. Beaujean F, Hartmann O, Kuentz M, Le FC, Divine M, Duedari N: A simple, efficient washing procedure for cryopreserved human hematopoietic stem cells prior to reinfusion. Bone Marrow Transplant 1991 8: 291 294
29. Rowley SD, Feng Z, Yadock D, Holmberg L, MacLeod B, Heimfeld S: Post-thaw removal of DMSO does not completely abrogate infusional toxicity or the need for pre-infusion histamine blockade. Cytotherapy 2008 1: 439 446
30. Keeney M, Chin-Yee I, Weir K, Popma J, Nayar R, Sutherland DR: Single platform flow cytometric absolute CD34+ cell counts based on the ISHAGE guidelines. International Society of Hematotherapy and Graft Engineering. Cytometry 1998 34: 61 70
31. Sauer-Heilborn A, Kadidlo D, McCullough J: Patient care during infusion of hematopoietic progenitor cells. Transfusion 2004 44: 907 916
32. Milone G, Mercurio S, Strano A, Leotta S, Pinto V, Battiato K, Coppoletta S, Murgano P, Farsaci B, Privitera A, Giustolisi R: Adverse events after infusions of cryopreserved hematopoietic stem cells depend on non-mononuclear cells in the infused suspension and patient age. Cytotherapy 2007 9: 348 355
33. David NA: The pharmacology of dimethyl sulfoxide 1. Annu Rev Pharmacol 1972 12: 353 374
34. Windrum P, Morris TC, Drake MB, Niederwieser D, Ruutu T: Variation in dimethyl sulfoxide use in stem cell transplantation: a survey of EBMT centres. Bone Marrow Transplant 2005 36: 601 603
35. Calmels B, Lemarie C, Esterni B, Malugani C, Charbonnier A, Coso D, de Colella JM, Deconinck E, Caillot D, Viret F, Ladaique P, Lapierre V, Chabannon C: Occurrence and severity of adverse events after autologous hematopoietic progenitor cell infusion are related to the amount of granulocytes in the apheresis product. Transfusion 2007 47: 1268 1275
36. Bojanic I, Cepulic BG, Mazic S, Batinic D, Nemet D, Labar B: Toxicity related to autologous peripheral blood haematopoietic progenitor cell infusion is associated with number of granulocytes in graft, gender and diagnosis of multiple myeloma. Vox Sang 2008 95: 70 75
37. Cordoba R, Arrieta R, Kerguelen A, Hernandez-Navarro F: The occurrence of adverse events during the infusion of autologous peripheral blood stem cells is related to the number of granulocytes in the leukapheresis product. Bone Marrow Transplant 2007 40: 1063 1067
38. Hequet O, Dumontet C, El Jaafari-Corbin A, Salles G, Espinouse D, Arnaud P, Thieblemont C, Bouafia F, Coiffier B: Epileptic seizures after autologous peripheral blood progenitor infusion in a patient treated with high-dose chemotherapy for myeloma. Bone Marrow Transplant 2002 29: 544
39. Windrum P, Morris TC: Severe neurotoxicity because of dimethyl sulphoxide following peripheral blood stem cell transplantation. Bone Marrow Transplant 2003 31: 315
40. Marcacci G, Corazzelli G, Becchimanzi C, Arcamone M, Capobianco G, Russo F, Frigeri F, Pinto A: DMSO-associated encephalopathy during autologous peripheral stem cell infusion: a predisposing role of preconditioning exposure to CNS-penetrating agents?. Bone Marrow Transplant 2009 44: 133 135
41. Mueller LP, Theurich S, Christopeit M, Grothe W, Muetherig A, Weber T, Guenther S, Behre G: Neurotoxicity upon infusion of dimethylsulfoxide- cryopreserved peripheral blood stem cells in patients with and without pre-existing cerebral disease. Eur J Haematol 2007 78: 527 531
42. Ferrucci PF, Martinoni A, Cocorocchio E, Civelli M, Cinieri S, Cardinale D, Peccatori FA, Lamantia G, Agazzi A, Corsini C, Tealdo F, Fiorentini C, Cipolla CM, Martinelli G: Evaluation of acute toxicities associated with autologous peripheral blood progenitor cell reinfusion in patients undergoing high-dose chemotherapy. Bone Marrow Transplant 2000 25: 173 177